---
figid: PMC5571822__lctt-8-109Fig1
figlink: /pmc/articles/PMC5571822/figure/f1-lctt-8-109/
number: Figure 1
caption: 'EGFR pathway and mechanism of action of osimertinib.Abbreviation: EGFR,
  epidermal growth factor receptor; TGF, transforming growth factor.'
pmcid: PMC5571822
papertitle: 'Osimertinib in the treatment of non-small-cell lung cancer: design, development
  and place in therapy.'
reftext: Mariacarmela Santarpia, et al. Lung Cancer (Auckl). 2017;8:109-125.
pmc_ranked_result_index: '110161'
pathway_score: 0.9437334
filename: lctt-8-109Fig1.jpg
figtitle: 'EGFR pathway and mechanism of action of osimertinib.Abbreviation: EGFR,
  epidermal growth factor receptor; TGF, transforming growth factor'
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5571822__lctt-8-109Fig1.html
  '@type': Dataset
  description: 'EGFR pathway and mechanism of action of osimertinib.Abbreviation:
    EGFR, epidermal growth factor receptor; TGF, transforming growth factor.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - NRAS
  - MTOR
  - MAP2K1
  - AKT1
  - AKT2
  - ARAF
  - AKT3
  - MAPK3
  - HRAS
  - BRAF
  - MAP2K2
  - JAK1
  - STAT3
  - NFKB1
  - RAF1
  - JAK2
  - KRAS
  - BCL2L11
  - EGF
  - MAPK1
  - TGFA
  - Cancer
  - Cardiomyopathy
  - Noonan syndrome
genes:
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: JAK1/2
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: STAT3
  symbol: STAT3
  source: hgnc_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: NF-KB
  symbol: NF-kappaB
  source: hgnc_alias_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: RAF
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: JAK1/2
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: BIM
  symbol: BIM
  source: hgnc_alias_symbol
  hgnc_symbol: BCL2L11
  entrez: '10018'
- word: EGF,TGF-a,Amphiregulin
  symbol: EGF
  source: hgnc_symbol
  hgnc_symbol: EGF
  entrez: '1950'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: EGF,TGF-a,Amphiregulin
  symbol: TGFA
  source: hgnc_symbol
  hgnc_symbol: TGFA
  entrez: '7039'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
---
